Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: The government said in a friend of the court brief filed on Friday that glyphosate, the weed killer’s active ingredient, is not a carcinogen and as a result a warning on the label was not required as California state law demands. The backing by the EPA and Justice Department comes days after Bayer asked a U.S. federal appeals court to throw out a $25 million judgment it was ordered to pay Edwin Hardeman. Bayer had denied its Roundup weed killer causes cancer. In April, the EPA reaffirmed that glyphosate does not cause cancer. Farmers spray glyphosate, the most widely used herbicide in U.S. agriculture, on fields of soybeans and other crops that are genetically engineered to resist it. Roundup is also used by consumers on lawns, golf courses and elsewhere. Hardeman’s lawyers previously accused Roundup maker Monsanto, which Bayer acquired last year in a $63 billion deal, of having failed to warn consumers about the herbicide’s cancer risk. Bayer stock has lost about 23% in value since the first Roundup verdict for plaintiffs in August 2018. Bayer argued it would be impossible to comply with the Hardeman verdict, a lawsuit brought under state law, because any warning label would be in conflict with guidance from a federal agency. The EPA and Justice Department agreed in their Friday filing. “It is unlawful for manufacturers and sellers to make claims on their labels that differ from what EPA approves,” the U.S. government said.
Example Output: More Breast Cancer Patients Should Consider Radiation, New Guidelines Say

Example Input: Cuomo’s cautiously upbeat report at a daily briefing came as the daily death toll across the state, the epicenter of the pandemic in the United States, dropped to 540 on April 17, down from 630 a day earlier and the lowest in more than two weeks. The governor said total hospitalizations of patients being treated for COVID-19, the respiratory illness caused by the coronavirus, came to 16,967, a drop of more than 1,300 over the past three days. Intubations and admissions to intensive care units also continued on their downward trend. “If you look at the past three days, you could argue that we are past the plateau and we’re starting to descend which would be very good news,” Cuomo said. He said, however, that about 2,000 infected people were newly admitted to hospitals on Friday, which he characterized as “still an overwhelming number,” and reiterated that he would take a cautious approach to reopening businesses and schools. Cuomo repeated a call for the federal government to help coordinate and provide funding for the mass testing that he and other governors have said is needed to determine when it is safe for people to go back to work. Providing new details on the challenge, Cuomo said a survey of labs in his state revealed an inability to procure the chemical reagents needed to run the tests on machines supplied by private manufacturers like Roche Holding AG. “They bought the machine, they have the machine, they have the test, but they need the reagents to do a higher volume of tests,” Cuomo said, adding that makers like Roche are struggling to get the reagents from China. “That’s the logjam we are in.”  New York disclosed 7,090 new positive cases over the last 24 hours for a total of 236,732 cases, while deaths increased by 540 to 13,362, marking by far the largest number of fatalities of any state. Even with stabilizing numbers, Cuomo said the pandemic was taking a severe emotional and economic toll on people, and estimated the impact on society would prove to be the biggest challenge facing the country since World War Two. “On every level this is a terrible experience, Cuomo said. “It is as tumultuous a time as we have ever seen.”
Example Output: New York Governor sounds optimistic note as coronavirus numbers improve.

Example Input: The story states that a $25 blood test can identify someone with a thyroid disorder. The costs associated with daily hormone therapy are not discussed. The article does an excellent job explaining the importance of thyroid hormones during pregnancy for fetal brain development, especially during the first trimester. It also points out the role in preventing miscarriage and premature birth. Furthermore, the story thoroughly details the risks that come with an overactive or an underactive thyroid gland for the average person. The article mentions that, for mild cases of hypothyroidism, scientists are unsure whether diagnoses and subsequent treatment sufficiently help pregnant patients or, instead, waste money on blood testing and thyroid medication. This is appropriately stated high up (in the first third) in the report. The article briefly mentions that the Quest Diagnostics study looked at records and surveys from half a million pregnant women, but apart from this fact, the story does not outline any more research methods or protocol. We could interpret the findings better if we knew, for example: There is no disease mongering in this story. The article gives appropriate and sufficient background information on various thyroid disorders and how they could affect pregnant women. The comment from Dr. Dena Goffman of New York’s Montefiore Medical Center offers an outside perspective on the research and the “long-running controversy” regarding thyroid testing for pregnant women. However, researchers at Quest Diagnostics – one of the world’s biggest companies for diagnostic services – conducted this study, which found a “higher-than-expected” number of pregnant women with underactive thyroids. Whether Quest Diagnostics funded the study, or whether Dr. Elizabeth Pearce had ties to the company, were not explicitly discussed. The story offers different perspectives and guidelines on thyroid screening from the American College of Obstetricians and Gynecologists and the American Thyroid Association. The story makes it clear that “nearly a quarter of pregnant women are getting the simple thyroid blood test regardless of whether they have symptoms.” Thyroid function screening via a blood test is not a new concept. The question is whether milder cases of hypothyroidism in pregnant women should be treated with daily hormone therapy. In general, the article does an excellent job laying out both sides of the issue. There was no evidence that the story relied solely on a press release.
Example Output:
Debate over who needs a thyroid check in pregnancy